BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wi TE, Ndowa FJ, Ferreyra C, Kelly-Cirino C, Taylor MM, Toskin I, Kiarie J, Santesso N, Unemo M. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward. J Int AIDS Soc 2019;22 Suppl 6:e25343. [PMID: 31468679 DOI: 10.1002/jia2.25343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Alharbi B, Cozzolino D, Sikulu-Lord M, Whiley D, Trembizki E. Near-infrared spectroscopy as a feasible method for the differentiation of Neisseria gonorrhoeae from Neisseria commensals and antimicrobial resistant from susceptible gonococcal strains. J Microbiol Methods 2022;201:106576. [PMID: 36096277 DOI: 10.1016/j.mimet.2022.106576] [Reference Citation Analysis]
2 Bitty-anderson AM, Gbeasor-komlanvi FA, Bakoubayi AW, Tchankoni MK, Sadio AJ, Salou M, Dagnra CA, Ekouevi DK, Coffie PA. High burden of self-reported sexually transmitted infections among female sex workers in Togo in 2021. Front Public Health 2022;10:915029. [DOI: 10.3389/fpubh.2022.915029] [Reference Citation Analysis]
3 Manhart LE, Geisler WM, Bradshaw CS, Jensen JS, Martin DH. Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches. Emerg Infect Dis 2022;28. [PMID: 35876565 DOI: 10.3201/eid2808.220094] [Reference Citation Analysis]
4 Medland NA, Zhang Y, Gunaratnam P, Lewis DA, Donovan B, Whiley DM, Guy RJ, Kaldor JM. Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: a global, systematic review, 1 January 2012 to 27 September 2020. Euro Surveill 2022;27. [PMID: 35514308 DOI: 10.2807/1560-7917.ES.2022.27.18.2100917] [Reference Citation Analysis]
5 Tadesse A, Geda A. Why Syphilis Infection is High Among Pregnant Women in Refugee Camps? A Case in Ethiopia. Int J Womens Health 2022;14:481-9. [PMID: 35392501 DOI: 10.2147/IJWH.S354045] [Reference Citation Analysis]
6 Hsieh K, Melendez JH, Gaydos CA, Wang TH. Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections. Lab Chip 2022. [PMID: 35048928 DOI: 10.1039/d1lc00665g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Loyez M, DeRosa MC, Caucheteur C, Wattiez R. Overview and emerging trends in optical fiber aptasensing. Biosens Bioelectron 2022;196:113694. [PMID: 34637994 DOI: 10.1016/j.bios.2021.113694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
8 Jia KM, Eilerts H, Edun O, Lam K, Howes A, Thomas ML, Eaton JW. Risk scores for predicting HIV incidence among adult heterosexual populations in sub-Saharan Africa: a systematic review and meta-analysis. J Int AIDS Soc 2022;25:e25861. [PMID: 35001515 DOI: 10.1002/jia2.25861] [Reference Citation Analysis]
9 Maina AN, Mureithi MW, Ndemi JK, Revathi G. Diagnostic accuracy of the syndromic management of four STIs among individuals seeking treatment at a health centre in Nairobi, Kenya: a cross-sectional study. Pan Afr Med J 2021;40:138. [PMID: 34909106 DOI: 10.11604/pamj.2021.40.138.25166] [Reference Citation Analysis]
10 Abisoye-Ogunniyan A, Carrano IM, Weilhammer DR, Gilmore SF, Fischer NO, Pal S, de la Maza LM, Coleman MA, Rasley A. A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections. Front Pharmacol 2021;12:768461. [PMID: 34899322 DOI: 10.3389/fphar.2021.768461] [Reference Citation Analysis]
11 Williams E, Fairley CK, Williamson D. Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections. Curr Opin Infect Dis 2021;34:591-8. [PMID: 34545855 DOI: 10.1097/QCO.0000000000000793] [Reference Citation Analysis]
12 Fuller SS, Clarke E, Harding-Esch EM. Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development. PLoS One 2021;16:e0259593. [PMID: 34748579 DOI: 10.1371/journal.pone.0259593] [Reference Citation Analysis]
13 Murtagh M, Blondeel K, Peeling RW, Kiarie J, Toskin I. The relevance of target product profiles for manufacturers, experiences from the World Health Organization initiative for point-of-care testing for sexually transmitted infections. Arch Public Health 2021;79:187. [PMID: 34706763 DOI: 10.1186/s13690-021-00708-y] [Reference Citation Analysis]
14 Gaydos CA, Manabe YC, Melendez JH. A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States. Sex Transm Dis 2021;48:S71-7. [PMID: 34110728 DOI: 10.1097/OLQ.0000000000001457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou Y, Jiang TT, Li J, Yin YP, Chen XS. Performance of point-of-care tests for the detection of chlamydia trachomatis infections: A systematic review and meta-analysis. EClinicalMedicine 2021;37:100961. [PMID: 34195578 DOI: 10.1016/j.eclinm.2021.100961] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Vargas S, Calvo G, Qquellon J, Vasquez F, Blondel K, Ballard R, Toskin I. Point-of-care testing for sexually transmitted infections in low-resource settings. Clin Microbiol Infect 2021:S1198-743X(21)00304-9. [PMID: 34118424 DOI: 10.1016/j.cmi.2021.05.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lannoy LH, Silva RJCD, Nahn Júnior EP, Oliveira EC, Gaspar PC. Brazilian Protocol for Sexually Transmitted Infections, 2020: infections that cause urethral discharge. Rev Soc Bras Med Trop 2021;54:e2020633. [PMID: 34008729 DOI: 10.1590/0037-8682-633-2020] [Reference Citation Analysis]
18 Dev R, Adhikari SP, Dongol A, Madhup SK, Pradhan P, Shakya S, Shrestha S, Maskey S, Taylor MM. Prevalence assessment of sexually transmitted infections among pregnant women visiting an antenatal care center of Nepal: Pilot of the World Health Organization's standard protocol for conducting STI prevalence surveys among pregnant women. PLoS One 2021;16:e0250361. [PMID: 33891652 DOI: 10.1371/journal.pone.0250361] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zenebe MH, Mekonnen Z, Loha E, Padalko E. Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia. PLoS One 2021;16:e0248958. [PMID: 33760867 DOI: 10.1371/journal.pone.0248958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Taku O, Brink A, Meiring TL, Phohlo K, Businge CB, Mbulawa ZZA, Williamson AL. Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa. PeerJ 2021;9:e10793. [PMID: 33717675 DOI: 10.7717/peerj.10793] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Caruso G, Giammanco A, Virruso R, Fasciana T. Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections. Int J Environ Res Public Health 2021;18:1038. [PMID: 33503917 DOI: 10.3390/ijerph18031038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
22 Peters R, Klausner JD, de Vos L, Feucht UD, Medina-Marino A. Aetiological testing compared with syndromic management for sexually transmitted infections in HIV-infected pregnant women in South Africa: a non-randomised prospective cohort study. BJOG 2021;128:1335-42. [PMID: 33277768 DOI: 10.1111/1471-0528.16617] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Adamson PC, Loeffelholz MJ, Klausner JD. Point-of-Care Testing for Sexually Transmitted Infections: A Review of Recent Developments. Arch Pathol Lab Med 2020;144:1344-51. [PMID: 32810868 DOI: 10.5858/arpa.2020-0118-RA] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ferreyra C, Osborn J, Moussy F, Alirol E, Lahra M, Whiley D, Shafer W, Unemo M, Klausner J, Kelly Cirino C, Wi T. Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus. PLoS One 2020;15:e0237424. [PMID: 32870912 DOI: 10.1371/journal.pone.0237424] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
25 Tobin L, Guerra L, Ahouanvoeke L, Carpio JG, Irambona D, Nyarko EO, Macera C, Wiersma S. Is it time to use nucleic acid amplification tests for identification of persons with sexually transmitted infections?: evidence from seroprevalence and behavioral epidemiology risk surveys in men with chlamydia and gonorrhea. Pan Afr Med J 2020;36:299. [PMID: 33117493 DOI: 10.11604/pamj.2020.36.299.20777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yuh T, Micheni M, Selke S, Oluoch L, Kiptinness C, Magaret A, Chohan B, Ngure K, Wald A, Mugo NR, Roxby AC. Sexually Transmitted Infections Among Kenyan Adolescent Girls and Young Women With Limited Sexual Experience. Front Public Health 2020;8:303. [PMID: 32766197 DOI: 10.3389/fpubh.2020.00303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Taylor MM, Wi TE. Transforming and integrating STI surveillance to enhance global advocacy and investment in STI control. J Int AIDS Soc 2019;22 Suppl 6:e25361. [PMID: 31468726 DOI: 10.1002/jia2.25361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Gaydos CA, Melendez JH. Point-by-Point Progress: Gonorrhea Point of Care Tests. Expert Rev Mol Diagn 2020;20:803-13. [PMID: 32500764 DOI: 10.1080/14737159.2020.1778467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
29 Van Der Pol B, Taylor SN, Mena L, Lebed J, McNeil CJ, Crane L, Ermel A, Sukhija-Cohen A, Gaydos CA. Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea. JAMA Netw Open 2020;3:e204819. [PMID: 32407506 DOI: 10.1001/jamanetworkopen.2020.4819] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
30 Gottlieb SL, Ndowa F, Hook EW 3rd, Deal C, Bachmann L, Abu-Raddad L, Chen XS, Jerse A, Low N, MacLennan CA, Petousis-Harris H, Seib KL, Unemo M, Vincent L, Giersing BK; Gonococcal Vaccine PPC Expert Advisory Group. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 2020;38:4362-73. [PMID: 32359875 DOI: 10.1016/j.vaccine.2020.02.073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
31 Cheng Y, Paintsil E, Ghebremichael M. Syndromic versus Laboratory Diagnosis of Sexually Transmitted Infections in Men in Moshi District of Tanzania. AIDS Res Treat 2020;2020:7607834. [PMID: 32089879 DOI: 10.1155/2020/7607834] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Chen W, Connor S, Gunathilake M. Men at risk of gonococcal urethritis: a case-control study in a Darwin sexual health clinic. BMC Infect Dis 2019;19:991. [PMID: 31752720 DOI: 10.1186/s12879-019-4625-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]